Table 1.
Dosage | ||
---|---|---|
Sepsis in a child aged <2 months | ||
Ampicillin intravenous | 50 mg/kg QID for 7–10 days (21 days for meningitis) | |
plus gentamicin intravenous | 5–7·5 mg/kg daily for 7–10 days (21 days for meningitis) | |
Second line: ceftriaxone intravenous | 50–100 mg/kg once daily for 7–10 days | |
Sepsis in a child aged <2 months where referral is not possible | ||
Amoxicillin oral | 50 mg/kg BID for 7 days | |
plus gentamicin intramuscular or intravenous | 5–7·5 mg/kg daily for 2–7 days | |
Sepsis in a child aged <2 months if skin conditions suggest Staphylococcus aureus | ||
Cloxacillin or flucloxacillin intravenous | 25–50 mg/kg BID or QID (age dependent) for 7–10 days | |
plus gentamicin | 5–7·5 mg/kg daily for 7–10 days (21 days for meningitis) | |
Sepsis in a child aged >2 months | ||
Ampicillin intravenous | 50 mg/kg QID for 7–10 days | |
plus gentamicin intravenous or intramuscular | 7·5 mg/kg daily for 7–10 days | |
Second line: ceftriaxone intravenous or intramuscular | 50 mg/kg BID or 100 mg/kg daily for 7–10 days | |
Sepsis in a child aged >2 months if skin conditions suggest S aureus | ||
Flucloxacillin intravenous | 50 mg/kg QID for 7–10 days | |
plus gentamicin | 7·5 mg/kg daily | |
Typhoid fever | ||
Ciprofloxacin oral | 15 mg/kg BID for 7–10 days | |
Second line: intravenous ceftriaxone | 80–100 mg/kg daily for 5–7 days | |
or azithromycin oral | 20 mg/kg daily for 5–7 days | |
Pneumonia | ||
Ampicillin intravenous | 50 mg/kg QID for 7–10 days | |
plus gentamicin intravenous | 7·5 mg/kg daily for 7–10 days | |
Second line: ceftriaxone intravenous | 80 mg/kg daily for 7–10 days | |
Pneumonia (if S aureus is suspected) | ||
Flucloxacillin or cloxacillin intravenous | 50 mg/kg QID for 7–10 days | |
plus gentamicin | 7·5 mg/kg intramuscular or intravenous once a day | |
Dysentery (presumed due to Shigella spp) | ||
Ciprofloxacin oral | 15 mg/kg BID for 3 days | |
Second line: ceftriaxone intravenous | 50–80 mg/kg daily for 3 days | |
Osteomyelitis | ||
Chloramphenicol | 25 mg/kg TID | |
Second line: cloxacillin or flucloxacillin intravenous | 50 mg/kg QID for up to 5 weeks (step down to oral once clinically improving) | |
or clindamycin or third-generation cephalosporins | No dosages specified; clear circumstances of when such therapy would be appropriate are not outlined | |
Meningitis in neonates | ||
Ampicillin | 50 mg/kg BID for 3 weeks | |
plus gentamicin | 5–7·5 mg/kg daily for 3 weeks | |
Ceftriaxone intravenous | 50–75 mg/kg daily for 3 weeks | |
plus gentamicin | 5–7·5 mg/kg daily for 3 weeks | |
Cefotaxime | 50 mg/kg BID or TID (age dependent) for 3 weeks | |
plus gentamicin | 5–7·5 mg/kg daily for 3 weeks | |
Meningitis in children older than 28 days | ||
Ceftriaxone intravenous | 50 mg/kg intramuscular or intravenous BID for 7–10 days | |
Second line: cefotaxime intravenous | 50 mg/kg intramuscular or intravenous QID for 7–10 days | |
Meningitis in children older than 28 days with no known resistance to chloramphenicol or β-lactams locally | ||
Chloramphenicol intravenous | 25 mg/kg QID for 10 days | |
plus ampicillin intramuscular or intravenous | 50 mg/kg QID for 10 days | |
or benzylpenicillin intravenous | 60 mg/kg QID for 10 days | |
Urinary tract infection | ||
Co-trimoxazole oral | 4 mg/kg plus 20 mg/kg BID for 5 days | |
Second line: ampicillin | 50 mg/kg intramuscular or intravenous every 6 h | |
plus gentamicin | 5–7·5 mg/kg daily |
First-line and second-line treatment guidelines for common paediatric infective illnesses. Data are from WHO pocket book of hospital care for children21 and WHO guideline for managing possible serious bacterial infection in young infants when referral is not feasible.22 BID=twice daily. TID=three times daily. QID=four times daily.